InvestSMART

LTR Pharma Ltd (ASX: LTP) - Share Price

- Current share price for LTP : $0.430

LTR Pharma Ltd's current share price is $0.43. This constitutes a share price movement of -4.44% when compared to its closing share price of $0.45 seven days ago. Relative to today's opening stock price, the LTP stock price is unchanged.

LTP General Information +

ASX Code LTP
Website N/A
Industry/Sector Pharmaceuticals
Market Cap ($M) 78
LTP Share Price $0.430
Day High $0.430
Day Low $0.430
Last Close $0.430
LTP Share Price Movement - ( No change )
Prices as at 12:45, 18 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

LTR Pharma Ltd (LTP) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from LTR Pharma Ltd (LTP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

LTR Pharma Ltd (LTP) price-sensitive announcements

LTP - LTR Secures Indian Patent Supporting SPONTAN and ROXUS
LTR Pharma Ltd (ASX: LTP) announced that the Indian Patent Office has formally granted Pat
LTR Pharma Ltd (LTP)
9 Nov 2026 | 8:52 AM
LTP - Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma Limited’s Quarterly Activities Report and Appendix 4C for the quarter ended 30
LTR Pharma Ltd (LTP)
28 Oct 2026 | 8:22 AM
LTP - First ROXUS Prescriptions Fulfilled in the United States
LTR Pharma Limited (ASX: LTP) announced that the first patient-specific ROXUS prescription
LTR Pharma Ltd (LTP)
6 Oct 2026 | 8:30 AM
LTP - SPONTAN Phase II Final Results
LTR Pharma announced that the final Clinical Study Report for its Phase II pharmacokinetic
LTR Pharma Ltd (LTP)
1 Oct 2026 | 8:24 AM

LTR Pharma Ltd (LTP) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 LTR Secures Indian Patent Supporting SPONTAN and ROXUS 9 Nov 2026 8:52AM $0.420 $0.430 risen by 2.38%
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 Application for quotation of securities - LTP 6 Nov 2026 7:04PM $0.420 $0.430 risen by 2.38%
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 Change of Director's Interest Notice - L Rodne 6 Nov 2026 6:56PM $0.420 $0.430 risen by 2.38%
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 Change of Director's Interest Notice - J Chick 6 Nov 2026 6:49PM $0.420 $0.430 risen by 2.38%
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 Change of Director's Interest Notice - M McGuire 6 Nov 2026 6:48PM $0.420 $0.430 risen by 2.38%
LTR Pharma Ltd (LTP)
ORDINARY FULLY PAID
Health Care $78 Notification regarding unquoted securities - LTP 6 Nov 2026 6:43PM $0.420 $0.430 risen by 2.38%

LTP Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$14.16 -$7.80 133.50% 0.00 0.00 0.00% 0.0%
2025A -$5.59 -$3.30 -33.10% 0.00 0.00 0.00% 0.0%
2024A -$6.95 -$5.00 379.80% 0.00 0.00 0.00% 0.0%

LTP Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Clarity Pharmaceuticals Ltd (CU6) $681M 0.4454 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
LTR Pharma Ltd (LTP) $81M 1.3353 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $2,913M -0.7857 0.2462 0.9655 98.7538 79.2414 40.3158 0.00% 1.52% 1.83%

LTP Directors

Name Position Start Date
Mr Lee Rodne Executive Chairman, Executive Director 7 Oct 2020
Dr Julian John Chick Non-Executive Director 25 Nov 2020
Ms Maja Aleksandra McGuire Non-Executive Director 6 Sep 2021

LTR Pharma Ltd (LTP) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value

See all changes in directors' interest & trades for LTR Pharma Ltd (LTP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

LTP Management

Name Position
Elizabeth Spooner Joint Company Secretary
Euh(David) Hwang Joint Company Secretary

LTP Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in LTR Pharma Ltd (LTP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
46,373,750 (25.51%) LTR Medical Pty Ltd

LTP Calendar of Events

Date Event
27 August 2027 Report (Annual)
27 August 2027 Report (Prelim)
25 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.